One platform for all researcher needs
AI-powered academic writing assistant
Your #1 AI companion for literature search
AI tool for graphics, illustrations, and artwork
Unlock unlimited use of all AI tools with the Editage All Access membership.
Explore Editage All Access
Search from 250 M+ research papersSearch from 250 M+ research papers
Open Accesshttps://doi.org/10.1182/blood-2019-123854
Copy DOI Journal: Blood |  Publication Date: Nov 13, 2019 |
 Citations: 67 |
Affiliation: Tennessee Oncology, Sarah Cannon, Clinica Universidad de Navarra, Eisai (United States), Dana-Farber Cancer Institute, Massachusetts General Hospital, Stanford University, Stanford Medicine, The University of Texas MD Anderson Cancer Center, Hospital General Universitario Gregorio Marañón, Jacksonville College, Mayo Clinic, Winneshiek Medical Center, Moffitt Cancer Center, Institut Gustave Roussy, Hospital Universitario HM Sanchinarro, Cleveland Clinic, Hospital Universitario Fundación Jiménez Díaz, Autonomous University of Madrid, Hôpital Saint-Louis, Beth Israel Deaconess Medical Center, Harvard University, University of North Carolina Health Care, Karmanos Cancer Institute, University of Miami Health System, Roswell Park Cancer Institute, Hannover Medical School, Memorial Sloan Kettering Cancer Center, University Hospital Leipzig, Colorado Blood Cancer Institute, University Hospital Carl Gustav Carus, Fred Hutch Cancer CenterResults of a Clinical Trial of H3B-8800, a Splicing Modulator, in Patients with Myelodysplastic Syndromes (MDS), Acute Myeloid Leukemia (AML) or Chronic Myelomonocytic Leukemia (CMML)
Sign-in/Register to access full text options 
Free) Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
